Assessment of enoxaparin thromboprophylaxis dosing and anti-factor Xa levels in low-weight patients.

被引：0
|
作者：
Yam, Lily [1 ]
Hong, Lisa [1 ]
机构：
[1] Loma Linda Univ, Sch Pharm, Loma Linda, CA 92350 USA
来源：
PHARMACOTHERAPY | 2016年 / 36卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
89
引用
收藏
页码：E108 / E109
页数：2
相关论文
共 50 条
  • [41] Anti-Factor Xa Monitoring of Enoxaparin Thromboembolism Prophylaxis in Emergency General Surgery Patients
    Pokrzywa, Courtney J.
    Biesboer, Elise A.
    Figueroa, Juan
    Al Tannir, Abdul Hafiz
    de Moya, Marc
    Morris, Rachel S.
    Murphy, Patrick B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (02) : 195 - 203
  • [42] Prophylactic dosing adjustment in pregnancy based upon measurements of anti-factor Xa levels
    Gyamfi, C
    Cohen, R
    Desancho, MT
    Gaddipati, S
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2005, 18 (05): : 329 - 331
  • [43] Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose
    Wall, Vanessa
    Fleming, Kory, I
    Tonna, Joseph E.
    Nunez, Jade
    Lonardo, Nick
    Shipley, R. Wayne
    Nirula, Ram
    Pannucci, Christopher J.
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 216 (02): : 222 - 229
  • [44] Safety and Efficacy of Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels in Pancreatic Surgery
    Kramme, Katherine
    Sarraf, Paya
    Shebrain, Saad
    Munene, Gitonga
    [J]. AMERICAN SURGEON, 2023, 89 (02) : 300 - 308
  • [45] Anti-Factor Xa Assay-A Changing Standard for Venous Thromboprophylaxis?
    Cook, Kristin
    Napolitano, Massimo
    Padberg, Frank T., Jr.
    [J]. JAMA SURGERY, 2016, 151 (11) : 1014 - 1014
  • [46] Fixed dosing regimes of enoxaparin for thromboprophylaxis do not reliably achieve target anti-Xa levels in women of normal weight during pregnancy
    Stock, Sarah J.
    Walker, Mairi C.
    Edelshain, Benjamin T.
    Horn, Lishel
    Norman, Jane E.
    Denison, Fiona C.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 158 (01) : 112 - 113
  • [47] Utility of anti-factor Xa levels in pregnant women receiving low molecular weight heparin prophylaxis
    Allred, Emily
    Quinn, Kristen
    Thorsen, Julia
    Pradarelli, Jason
    Baker, Lisa
    Szabo, Aniko
    Zhao, Shi
    Wassenaar, Timothy
    Kuhlman, Randall
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S280 - S280
  • [48] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    van Oosterom, Nameer
    Winckel, Karl
    Barras, Michael
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 387 - 393
  • [49] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    Nameer van Oosterom
    Karl Winckel
    Michael Barras
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 387 - 393
  • [50] Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
    David Oliver Hamilton
    Alexander Main-Ian
    Jessie Tebbutt
    Maya Thrasher
    Alicia Waite
    Ingeborg Welters
    [J]. Thrombosis Journal, 19
12345